Advertisement

Topics

The Sanofi BioGENEius Challenge Canada (SBCC) Company Profile

21:57 EDT 18th September 2018 | BioPortfolio


News Articles [1255 Associated News Articles listed on BioPortfolio]

BioKansas Selects Luann Jung as 2018 Kansas BioGENEius Challenge Winner

Jung to compete against students from across the globe in International BioGENEius Challenge BioKansas announced Luann Jung as the winner of the Kansas BioGENEius Chall...

Elite High School Scientists Headed To BIO2018 to Face Off in the BioGENEius Challenge

Today, the Biotechnology Institute announced the 15 student winners who will advance to the final stages of the 2018 BioGENEius Challenge this coming week at the BIO International...

Sanofi to open €350m vaccines facility in Canada

Sanofi is planning to build a new €350m vaccines manufacturing facility at its Canadian headquarters in Toronto. The expansion is...Read More... The post Sanofi to open €350m vaccines facility in ...

BioKansas to Host the 2018 Kansas BioGENEius Challenge Finals on Thursday, April 26th

BioKansas is hosting the 2018 Kansas BioGENEius Challenge Finals this Thursday, April 26th, at Aratana Therapeutics, 11400 Tomahawk Creek Parkway, Leawood, Kansas, 66211. BioKansa...

Sanofi Xyzal OTC Antihistamine Claims Lose Second Challenge In Six Months

Sanofi will modify claims in social media ads that its Xyzal Allergy 24HR antihistamine is 'twice as fast' as Bayer's s...  

Georgia Bio Names Mountain View High School Junior as Georgia BioGENEius Winner

Suraj Modi Advances to Boston to International Competition Against Top Students Atlanta, GA (April 6, 2018) – Georgia Bio and the Georgia BioEd Institute today named Suraj Modi, Mountain View H...

Sanofi to build 350 million-euro vaccine unit in Canada

French pharma major Sanofi has shown the faith that it has in its vaccines business by investing 350…

High School Student from Waterloo Receives Top Honor at International BioGENEius Challenge

Students from California, Washington and Germany named runners-up Sajeev Kohli (11th Grade, Waterloo, On, Canada) was named the grand prize winner of the International BioGENE...

Drugs and Medications [418 Associated Drugs and Medications listed on BioPortfolio]

Aridol bronchial challenge test kit [Pharmaxis Ltd]

These highlights do not include all the information needed to use ARIDOL safely and effectively. See full prescribing information for ARIDOL. ARIDOL™ (mannitol inhalation powder) Bronchial Challenge...

Derma sciences [Derma Sciences Canada, Inc.]

Drug Facts

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Colgate triple action original mint fluoride [Colgate-Palmolive Canada]

Colgate Triple Action Original Mint

As [CaridianBCT, Inc.]

Additive Solution Formula 3

PubMed Articles [713 Associated PubMed Articles listed on BioPortfolio]

The SbcC and SbcD homologs of the cyanobacterium Anabaena sp. strain PCC7120 (Alr3988 and All4463) contribute independently to DNA repair.

The ubiquitous SbcCD exonuclease complex has been shown to perform an important role in DNA repair across prokaryotes and eukaryotes. However, they have remained uncharacterized in the ancient and str...

Cryosurgery + 5% 5-Fluorouracil for Treatment of Superficial Basal Cell Carcinoma and Bowen's Disease.

Superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis) are 2 types of nonmelanoma skin cancers (NMSCs) that are amenable to treatment with topical 5-fluorouracil, cryosurg...

Association between patient attachment to a regular doctor and self-perceived unmet health care needs in Canada: A population-based analysis of the 2013 to 2014 Canadian community health surveys.

Although Canada operates a universal health care insurance system, equitable access to required health care services when needed still poses a challenge for some. The aim of this study was to examine ...

Photodynamic Therapy Activated by Intense Pulsed Light in the Treatment of Nonmelanoma Skin Cancer.

Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) has proven to be a highly effective conservative method for the treatment of actinic keratosis (AK),...

Tuberculosis-related hospital use among recent immigrants to Canada.

While the incidence of active tuberculosis (TB) in Canada is among the lowest in the world, the rates of TB among immigrants and Indigenous people remain high. In fact, the majority of new active TB c...

Clinical Trials [1422 Associated Clinical Trials listed on BioPortfolio]

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas(sBCC)

A double-blind, randomized, vehicle-controlled Proof of Concept (PoC) study to evaluate the efficacy, safety, local tolerability, pharmacokinetics and pharmacodynamics of multiple topical ...

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Exercise Challenge in a Cold Chamber

The purpose of this study is to compare the exercise-challenge in a cold chamber at 2-4°C to the gold standard the metacholine challenge in subjects showing symptoms of exercise-induced b...

Bioequivalence Study of 2.5 mg Saxagliptin and 500 mg Glucophage Combination Formulations in Healthy Subjects

To demonstrate bioequivalence of a 2.5 mg saxagliptin/500 mg metformin fixed dose combination (FDC) tablet to the 2.5 mg saxagliptin tablet and 500 mg metformin (Glucophage Marketed in Can...

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

This is phase I, double blind, placebo-controlled safety and infectivity study of experimental human Norovirus genogroup GII.4 administered to healthy adults 18-49 years of age. Subjects s...

Companies [979 Associated Companies listed on BioPortfolio]

The Sanofi BioGENEius Challenge Canada (SBCC)

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SA...

Sanofi Pharmaceuticals Incorporated

Sanofi Pharmaceuticals are the U.S. subsidiary of Sanofi-Synthelabo, the global healthcare company. With annual sales in excess of $5.6 billion and 30,000 employees in more than 100 countries, Sanofi-...

More Information about "The Sanofi BioGENEius Challenge Canada (SBCC)" on BioPortfolio

We have published hundreds of The Sanofi BioGENEius Challenge Canada (SBCC) news stories on BioPortfolio along with dozens of The Sanofi BioGENEius Challenge Canada (SBCC) Clinical Trials and PubMed Articles about The Sanofi BioGENEius Challenge Canada (SBCC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Sanofi BioGENEius Challenge Canada (SBCC) Companies in our database. You can also find out about relevant The Sanofi BioGENEius Challenge Canada (SBCC) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record